Stock Analiz

AMGN vs BIIB stock comparison

Amgen vs. Biogen · data as of November 13, 2026

Amgen (AMGN) has a market value of about $251.9B, Biogen (BIIB) about $37.5B. Over their latest twelve months Amgen had revenue of $38.9B and Biogen $10.3B.

On our five checks Amgen scores higher: 2.4 out of 5 (weak) against 1.8 (weak).

By area, the stronger company is Biogen on value; Amgen on future growth; Amgen on track record; Biogen on financial health; Amgen on shareholder returns.

Amgen is cheaper on earnings (P/E 27.0 vs. 109.2).

Amgen leads on 16 of the compared lines and Biogen on 8.

Side by side

AMGNBIIB
Size and price
Market cap$251.9B$37.5B
Share price$465.67$253.40
Score
Overall score (of 5)2.41.8
Value01
Future growth32
Track record31
Financial health24
Shareholder returns41
Valuation
P/E (TTM)27.0109.2
Forward P/E19.517.4
Price / free cash flow26.318.1
Price / sales6.53.6
EV / EBITDA17.126.7
PEG9.18—
DCF value vs. price−26%−33%
Business
Revenue$38.9B$10.3B
Net income$9.4B$348M
Free cash flow$9.6B$2.1B
Net margin24.1%3.4%
Gross margin (5-yr avg.)69.9%76.9%
ROIC (5-yr avg.)13.5%9.2%
Growth
Revenue growth (1 yr)10.0%2.2%
Revenue growth (5 yrs, per year)7.6%-6.0%
EPS growth (5 yrs, per year)2.9%-18.7%
Balance sheet and payouts
Net cash (cash minus debt)-$40.8B-$6.1B
Dividend yield2.16%None
Shareholder yield2.2%0.0%
Analysts
Upside to average target−7%+6%
Consensus ratingHoldBuy

Highlighted = the better figure on that line. Revenue, net income and free cash flow: AMGN TTM to September 30, 2026, BIIB TTM to September 30, 2026. Not investment advice.

Frequently asked questions

Which is the better stock, Amgen or Biogen?

We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Amgen scores 2.4 out of 5 and Biogen 1.8; the table shows where each one is stronger.

Is Amgen cheaper than Biogen?

On trailing earnings, Amgen trades at a P/E of 27.0 and Biogen at 109.2, so Amgen is cheaper by this measure. A lower P/E can also reflect slower expected growth.

Which grows faster, Amgen or Biogen?

Over five years Amgen grew revenue about 7.6% a year and Biogen about -6.0% a year.

Which pays a higher dividend?

Amgen yields 2.16% and Biogen nothing (no dividend).

Full Amgen analysis → Full Biogen analysis →

More comparisons

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.